132 related articles for article (PubMed ID: 3024885)
1. Expression of Tac antigen in B cell lymphomas.
Laurent G; Al Saati T; Olive D; Laurent JC; Poncelet P; Delsol G
Clin Exp Immunol; 1986 Aug; 65(2):354-62. PubMed ID: 3024885
[TBL] [Abstract][Full Text] [Related]
2. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
[TBL] [Abstract][Full Text] [Related]
3. The demonstration of B-cell, T-cell and myeloid antigens in paraffin sections.
West KP; Warford A; Fray L; Allen M; Campbell AC; Lauder I
J Pathol; 1986 Oct; 150(2):89-101. PubMed ID: 3540244
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic expression of B lymphocytes. III. Marginal zone B cells in the spleen are characterized by the expression of Tac and alkaline phosphatase.
Hsu SM
J Immunol; 1985 Jul; 135(1):123-30. PubMed ID: 2987343
[TBL] [Abstract][Full Text] [Related]
5. Surface membrane phenotypic expression and treatment response of malignant lymphomas.
Lauder I; Bird CC; Child JA; Grigor I
J Pathol; 1985 Mar; 145(3):259-68. PubMed ID: 3920370
[TBL] [Abstract][Full Text] [Related]
6. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
7. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
[TBL] [Abstract][Full Text] [Related]
8. [Immunoperoxidase study of normal and pathologic lymphoid tissue. Value of monoclonal antibodies].
Delsol G; Al Saati T; Caveriviere P; Voigt JJ; Ancelin E; Rigal-Huguet F
Ann Pathol; 1984; 4(3):165-83. PubMed ID: 6383412
[TBL] [Abstract][Full Text] [Related]
9. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia.
Lai R; Arber DA; Chang KL; Wilson CS; Weiss LM
Mod Pathol; 1998 Sep; 11(9):864-9. PubMed ID: 9758366
[TBL] [Abstract][Full Text] [Related]
10. Nuclear antigens in neoplastic lymphocytes of B cell and T cell non-Hodgkin's lymphomas.
Dardick I; Hall R; Bailey DJ; Stratis M; Brown DL; Chaly N
Am J Pathol; 1989 Jan; 134(1):213-22. PubMed ID: 2783638
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sections.
Marder RJ; Variakojis D; Silver J; Epstein AL
Lab Invest; 1985 May; 52(5):497-504. PubMed ID: 3887032
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
14. [Phenotypic and genotypic marker in malignant lymphomas: cellular origin of Hodgkin's disease and malignant histiocytosis as well as implications for classifying T-cell and B-cell lymphomas].
Stein H; Gerdes J
Verh Dtsch Ges Pathol; 1986; 70():127-51. PubMed ID: 3548121
[No Abstract] [Full Text] [Related]
15. Immunohistologic localization and immune phenotypes of lymphocytes expressing Tac antigen in human lymphoid tissues.
Miyawaki T; Ohzeki S; Ikuta N; Seki H; Taga K; Taniguchi N
J Immunol; 1984 Dec; 133(6):2996-3000. PubMed ID: 6092463
[TBL] [Abstract][Full Text] [Related]
16. Expression of Tac antigen by non-Hodgkin's lymphomas.
Weiss LM; Michie SA; Medeiros LJ; Strickler JG; Garcia CF; Warnke RA
Am J Clin Pathol; 1987 Oct; 88(4):483-5. PubMed ID: 2821794
[TBL] [Abstract][Full Text] [Related]
17. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
18. Low-grade lymphomas. Expression of developmentally regulated B-cell antigens.
Cossman J; Neckers LM; Hsu S; Longo D; Jaffe ES
Am J Pathol; 1984 Apr; 115(1):117-24. PubMed ID: 6201073
[TBL] [Abstract][Full Text] [Related]
19. Distribution of cells bearing the Tac antigen during ontogeny of human lymphoid tissue.
Hofman FM; Modlin RL; Bhoopat L; Taylor CR
J Immunol; 1985 Jun; 134(6):3751-5. PubMed ID: 2985695
[TBL] [Abstract][Full Text] [Related]
20. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
